Tempus AI, Inc. (NASDAQ:TEM) Given Average Rating of “Hold” by Brokerages

Shares of Tempus AI, Inc. (NASDAQ:TEM) have been assigned a consensus rating of “Hold” from the fifteen brokerages that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $68.6429.

A number of equities research analysts recently issued reports on TEM shares. Mizuho started coverage on shares of Tempus AI in a report on Thursday, February 19th. They issued an “outperform” rating and a $100.00 price objective for the company. Jefferies Financial Group began coverage on shares of Tempus AI in a report on Monday, April 13th. They set an “underperform” rating and a $35.00 price objective on the stock. HC Wainwright lowered their target price on shares of Tempus AI from $95.00 to $64.00 and set a “buy” rating on the stock in a research note on Monday, May 11th. Wall Street Zen raised shares of Tempus AI from a “sell” rating to a “hold” rating in a research note on Saturday. Finally, Needham & Company LLC reissued a “buy” rating and issued a $75.00 target price on shares of Tempus AI in a research note on Monday, June 1st.

Tempus AI Trading Up 4.7%

Shares of NASDAQ:TEM opened at $48.59 on Tuesday. The stock has a market capitalization of $8.73 billion, a PE ratio of -28.25 and a beta of 3.64. Tempus AI has a 1 year low of $41.73 and a 1 year high of $104.32. The firm has a fifty day moving average price of $48.95 and a 200 day moving average price of $57.29. The company has a current ratio of 3.31, a quick ratio of 3.15 and a debt-to-equity ratio of 2.96.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings data on Tuesday, May 5th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.08. The firm had revenue of $348.12 million during the quarter, compared to analysts’ expectations of $345.44 million. Tempus AI had a negative net margin of 22.20% and a negative return on equity of 53.83%. Tempus AI’s revenue for the quarter was up 36.1% on a year-over-year basis. During the same period in the prior year, the company posted ($0.24) earnings per share. Analysts expect that Tempus AI will post -1.35 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, EVP Andrew Polovin sold 8,703 shares of the company’s stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $44.07, for a total value of $383,541.21. Following the sale, the executive vice president owned 128,215 shares of the company’s stock, valued at $5,650,435.05. The trade was a 6.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO James William Rogers sold 10,853 shares of the company’s stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $44.07, for a total transaction of $478,291.71. Following the completion of the sale, the chief financial officer directly owned 126,395 shares in the company, valued at approximately $5,570,227.65. The trade was a 7.91% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 558,557 shares of company stock valued at $26,611,939 over the last 90 days. Company insiders own 24.26% of the company’s stock.

Institutional Trading of Tempus AI

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Victory Capital Management Inc. increased its stake in Tempus AI by 1.5% in the third quarter. Victory Capital Management Inc. now owns 11,078 shares of the company’s stock valued at $894,000 after acquiring an additional 162 shares during the period. US Bancorp DE increased its stake in Tempus AI by 6.6% in the third quarter. US Bancorp DE now owns 2,848 shares of the company’s stock valued at $230,000 after acquiring an additional 176 shares during the period. Legacy Bridge LLC increased its stake in Tempus AI by 1.6% in the fourth quarter. Legacy Bridge LLC now owns 12,418 shares of the company’s stock valued at $733,000 after acquiring an additional 193 shares during the period. Truist Financial Corp grew its stake in Tempus AI by 5.8% during the fourth quarter. Truist Financial Corp now owns 3,532 shares of the company’s stock worth $209,000 after buying an additional 194 shares during the last quarter. Finally, Farther Finance Advisors LLC grew its stake in Tempus AI by 3.5% during the fourth quarter. Farther Finance Advisors LLC now owns 6,390 shares of the company’s stock worth $377,000 after buying an additional 219 shares during the last quarter. Institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.